跳至主要内容
临床试验/NCT00716664
NCT00716664已完成不适用

Pilot Study: Do Physiotherapy Musculoskeletal Techniques Improve Forced Expiratory Volume in One Second in Adults With Cystic Fibrosis?

Royal Brompton & Harefield NHS Foundation Trust2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2007年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Forced expiratory volume in one second

研究概览

简要总结

The pilot study aims to evaluate the effects of a treatment series of gentle joint and muscle movements (in addition to normal optimal care)on lung function, exercise capacity and posture in stable adults with cystic fibrosis.

详细描述

Study type:

Prospective, single-blinded, randomised control trial

Consent

  • Prospective subjects will be given written and verbal information about the project and will be given at least 24 hours to consider entry to the study.
  • Subjects will give written consent to participate in the project. The top copy will be included in the patient's medical record and a copy placed in the patient's study file.
  • A letter will be written to the subject's General Practitioner outlining the purpose of the study and inviting him/her to make contact to discuss the study in more detail if there are any queries or concerns.
  • At the time of consent, the appointments for the duration of the interventions and potential follow-up will be made.

Intervention for the treatment group A treatment series of gentle joint and muscle movements (musculoskeletal interventions) will be undertaken by a physiotherapist, weekly, for six weeks. A chaperone would be available if requested by the subject (the patients would be made aware of this when informed about the study.)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Reported postural changes, stiffness, discomfort and/or pain of musculoskeletal origin in the thoracic spine or chest wall.
  • Diagnosis of cystic fibrosis (confirmed by genotype or a sweat sodium concentration of >70mmol/l or sweat chloride of >60mmol/l)
  • Sixteen years of age or over
  • Patients in a stable clinical state with lung function at the time of entry that is within 10% of the mean of the last two recordings (separated by at least one month).
  • Forced Expiratory Volume in 1 second (FEV1) ≥30% predicted at time of entry to the study.

排除标准

  • Evidence of a current respiratory exacerbation (worsening) as defined by Thornton et al. 2004
  • Cor pulmonale (right heart failure)
  • Low bone density (Z score < -3)(WHO Study Group 1994)
  • Previous history of spontaneous fractures
  • Past history of spinal fracture or other known arthropathic (joint) or spinal disease process
  • Currently undergoing musculoskeletal (physiotherapy, chiropractic or osteopathic) treatment
  • Pregnancy
  • Inability to give consent
  • Current enrollment in another research trial.

结局指标

主要结局

Forced expiratory volume in one second

时间窗: 12 weeks

次要结局

  • Forced vital capacity, peak expiratory flow rate(12 weeks)
  • Visual analogue scale for pain(12 weeks)
  • Modified shuttle test(12 weeks)
  • The Cystic Fibrosis Quality of Life Questionnaire, section one: physical functioning(12 weeks)
  • Flexi curve measurements of posture(12 weeks)
  • Chest wall excursion measurements(12 weeks)
  • Full lung function will be measured ≤ one month prior to the start of the study and at the end of the intervention period(12 weeks)
  • Questionnaire II - the subject's perspective(12 weeks)

研究者

研究点 (2)

Loading locations...

相似试验